Weight-based heparin dosing: clinical response and resource utilization

Area of Science:

• Pharmacology
• Clinical Medicine
• Health Services Research

Background:

• Heparin is a critical anticoagulant for venous thromboembolism (VTE) and unstable angina.
• Optimizing heparin dosing is essential for efficacy and safety.
• Weight-based heparin (WBH) nomograms aim to standardize anticoagulation initiation.

Purpose of the Study:

• To evaluate a specific weight-based heparin (WBH) nomogram (80-U/kg bolus, 18-U/kg/hr infusion).
• To assess the clinical performance and resource utilization of WBH.
• To identify factors influencing heparin response and optimize nomogram recommendations.

Main Methods:

• Retrospective chart review of patients receiving heparin for VTE or unstable angina.
• Comparison of three groups: WBH, deviated (DEV) regimens, and historical controls (HCs).
• Analysis of activated partial thromboplastin time (aPTT) levels, bleeding events, and resource utilization.

Main Results:

• WBH patients reached therapeutic aPTT levels faster than HC or DEV groups.
• 42% of WBH patients experienced supratherapeutic responses; age, prior warfarin, and high infusion rates were predictive.
• An infusion rate of 15 U/kg/hr approximated actual requirements, and bleeding events were similar across groups.
• Significant differences in nursing interventions were observed between WBH and HC groups.

Conclusions:

• WBH effectively and rapidly elevates aPTT into the therapeutic range.
• Initial infusion rate adjustment is necessary to avoid supratherapeutic responses.
• A WBH nomogram with an initial infusion rate of 15 U/kg/hr is supported by the data for this population.